Nektar Hurting Shorts With Positive Results From NKTR-181 Study
March 20, 2017 at 10:52 AM EDT
Nektar Therapeutics (NASDAQ: NKTR) shares are trading higher by $5.00 (33 percent) at $20.50 in Monday's session. The catalyst for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.